Operating Segments (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Reportable Segments Summarized Financial Information

Summarized financial information concerning our reportable segments is shown in the following table. Results for 2013 have been recast to reflect the change in operating segments noted above, and segment results for all periods presented exclude discontinued operations as further described in Notes 1 and 15. Corporate & other includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to each segment whereas the remaining components of pension and OPEB benefits cost or credit are included in Corporate & other.

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2014			2013			2014			2013
	(In thousands)
Net sales:
Performance Chemicals	$	364,517		$	365,154		$	1,048,961		$	1,059,202
Catalyst Solutions	277,901			226,042			798,021			695,433
Total net sales	$	642,418		$	591,196		$	1,846,982		$	1,754,635
Segment operating profit:
Performance Chemicals	$	86,983		$	91,506		$	244,724		$	265,665
Catalyst Solutions	53,039			47,205			162,169			125,615
Total segment operating profit	140,022			138,711			406,893			391,280
Equity in net income of unconsolidated investments:
Performance Chemicals	1,744			1,735			7,321			6,371
Catalyst Solutions	6,906			3,603			20,879			18,937
Total equity in net income of unconsolidated investments	8,650			5,338			28,200			25,308
Net income attributable to noncontrolling interests:
Performance Chemicals	(8,546		)	(7,332		)	(23,130		)	(21,250		)
Total net income attributable to noncontrolling interests	(8,546		)	(7,332		)	(23,130		)	(21,250		)
Segment income:
Performance Chemicals	80,181			85,909			228,915			250,786
Catalyst Solutions	59,945			50,808			183,048			144,552
Total segment income	140,126			136,717			411,963			395,338
Corporate & other(a)	(22,995		)	(9,909		)	(76,528		)	(41,715		)
Restructuring and other charges, net	(293		)	—			(20,625		)	—
Acquisition and integration related costs	(10,261		)	—			(15,104		)	—
Interest and financing expenses	(8,749		)	(9,496		)	(26,255		)	(22,335		)
Other expenses, net	(6,618		)	(368		)	(6,454		)	(6,147		)
Income tax expense	(11,737		)	(26,963		)	(46,700		)	(72,897		)
(Loss) income from discontinued operations (net of tax)	(6,679		)	531			(68,473		)	4,994
Net income attributable to Albemarle Corporation	$	72,794		$	90,512		$	151,824		$	257,238

(a) For the three months ended September 30, 2014 and 2013, Corporate & other includes $(1.9) million and $1.0 million, respectively, of pension and OPEB plan (costs) credits, and for the nine months ended September 30, 2014 and 2013, Corporate & other includes $(15.7) million and $3.1 million, respectively, of pension and OPEB plan (costs) credits.